Intellectual Property Law

USPTO Suggestions for Effectively Reducing the Application Backlog
Greg Aharonian's Internet Patent News Service has posted a copy of the USPTO's response to twenty questions of the Congressional Subcommittee on the Courts, Internet, and Intellectual Property following the subcommittee hearing on February 27, 2008...

Fast-Track Canadian Patents
The Canadian Intellectual Property Office has announced its participation in the  Canada-U.S. Patent Prosecution Highway (PPH) pilot project.  This experimental program, which has been in the works for some time, is designed to help fast-track patent examination in both Canada and the U...

Patent Prosecution Highway Programs Streamline Global Patent Process
This week the U.S. Patent and Trademark Office announced its sixth “patent prosecution highway” (PPH) program to fast-track global patent examination procedures when the patent office of any participating country has deemed a patent application to be allowable...

A Peek Behind the Scenes in the Patent Academy
A student at the Patent Academy has started a blog.'Relativity' writes a nearly daily entry about his/her experiences at the Academy, about the classes, the quizzes, and yes, even the team building exercises...

Improper Final Rejections and Suggestions for Avoiding Them (and Hopefully the Expense Of Having to Request Their Withdrawal)
Patent examination in the U.S. Patent Office is guided by the principles of compact prosecution, which I discussed in some detail in an earlier post here. Under the principles of compact prosecution, second Office actions are typically final...

Gilead claims rejected in re-examination
MedicalNewsToday reported:The U.S. Patent and Trademark Office on Wednesday (Jan. 23) rejected four patents on Gilead Sciences' antiretroviral drug Viread, Reuters reports. Viread is known generically as tenofovir and is sold as part of Gilead's combination therapies Truvada and Atripla...

Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.

Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.

DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Sony
to Pay $18.5 Million For Patent Infringment

Qualcomm Settles Patent Suit for $891 Million

The Princeton Review
$2.6 million settlement reached in patent infringement case.